Iovance Biotherapeutics (IOVA) went public on October 15, 2010, when it opened at a split-adjusted price of $105.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
January 2025 | $7.54 | $8.15 | $7.00 | $7.17 | 36,720,463 |
December 2024 | $9.28 | $9.38 | $7.05 | $7.40 | 124,775,200 |
November 2024 | $10.62 | $12.51 | $7.98 | $9.32 | 182,871,400 |
October 2024 | $9.30 | $11.33 | $8.97 | $10.44 | 106,236,200 |
September 2024 | $11.50 | $11.80 | $8.80 | $9.39 | 110,238,000 |
August 2024 | $8.86 | $12.50 | $7.11 | $11.66 | 163,851,700 |
July 2024 | $8.02 | $10.12 | $7.17 | $8.73 | 137,407,400 |
June 2024 | $8.87 | $9.25 | $7.59 | $8.02 | 158,952,200 |
May 2024 | $11.75 | $14.23 | $8.86 | $8.88 | 137,340,300 |
April 2024 | $14.71 | $14.77 | $11.01 | $11.78 | 92,333,800 |
March 2024 | $16.36 | $18.24 | $13.60 | $14.82 | 153,540,700 |
February 2024 | $7.85 | $18.33 | $7.60 | $15.91 | 304,726,200 |
January 2024 | $7.98 | $10.31 | $7.34 | $7.73 | 137,407,600 |
December 2023 | $6.05 | $9.03 | $5.76 | $8.13 | 189,673,200 |
November 2023 | $3.84 | $6.58 | $3.74 | $6.07 | 153,322,400 |
October 2023 | $4.55 | $4.60 | $3.21 | $3.82 | 119,365,700 |
September 2023 | $6.07 | $6.47 | $4.36 | $4.55 | 182,939,800 |
August 2023 | $7.22 | $7.93 | $5.98 | $6.04 | 97,066,400 |
July 2023 | $7.06 | $8.82 | $6.80 | $7.26 | 111,991,300 |
June 2023 | $8.75 | $9.14 | $6.93 | $7.04 | 120,999,700 |
May 2023 | $5.70 | $9.36 | $5.59 | $8.74 | 150,093,500 |
April 2023 | $6.13 | $6.44 | $5.28 | $5.64 | 57,553,400 |
March 2023 | $7.32 | $7.62 | $5.39 | $6.11 | 88,418,700 |
February 2023 | $7.95 | $8.49 | $6.83 | $7.29 | 60,770,000 |
January 2023 | $6.44 | $8.43 | $5.92 | $7.96 | 104,841,000 |
